Aurinia Pharmaceuticals Inc banner

Aurinia Pharmaceuticals Inc
F:IKAP

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
F:IKAP
Watchlist
Price: 13.16 EUR -2.34% Market Closed
Market Cap: €1.9B

Dividends

Aurinia Pharmaceuticals Inc
does not pay dividends

Shareholder Yield

Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Peers Comparison
Shareholder Yield

Buybacks

Buyback Yield
Aurinia Pharmaceuticals Inc

Period
3Y
5Y
10Y
15Y
30Y
Buyback Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Buybacks

Debt Paydown

Debt Paydown Yield
Aurinia Pharmaceuticals Inc

Period
3Y
5Y
10Y
15Y
30Y
Debt Paydown Yield, Past 5 Years
Min
Max
Current Yield
Min Yield
Max Yield
Average Yield
Median Yield

Peers Comparison
Debt Paydown

Price Appreciation

IKAP Price
Aurinia Pharmaceuticals Inc

Annual Price Range
13.16
52w Low
7.546
52w High
16.395
Price Metrics
Average Annual Return 28.25%
Standard Deviation of Annual Returns 82.73%
Max Drawdown -88%
Shares Statistics
Market Capitalization 2B EUR
Shares Outstanding 142 984 000
Percentage of Shares Shorted
N/A

IKAP Return Decomposition
Main factors of price return

Stock Splits

IKAP's latest stock split occurred on Oct 23, 2013

The company executed a 1-for-50 stock split, meaning that for every 50 shares held, investors received 1 new share.

Before the split, IKAP traded at 0.025 per share. Afterward, the share price was about 2.15.

The adjusted shares began trading on Oct 23, 2013. This was the only stock split in IKAP's history.

Pre-Split Price
1.25 0.025
Post-Split Price
2.15
Before
After
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett